Open-Label Phase 2 Pilot Study of Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE)

J Drugs Dermatol. 2023 Apr 1;22(4):425-427. doi: 10.36849/JDD.7098.

Abstract

Alsukait S, Learned C, Rosmarin D. Open-label phase 2 pilot study of oral tofacitinib in adult subjects with Discoid Lupus Erythematosus (DLE). J Drugs Dermatol. 2023;22(4): 425-427. doi:10.36849/JDD.7098.

Publication types

  • Clinical Trial, Phase II

MeSH terms

  • Adult
  • Humans
  • Lupus Erythematosus, Discoid* / diagnosis
  • Lupus Erythematosus, Discoid* / drug therapy
  • Pilot Projects
  • Piperidines* / adverse effects
  • Pyrimidines

Substances

  • Piperidines
  • tofacitinib
  • Pyrimidines